Venetoclax-based regimens show safety and efficacy in octogenarian patients with chronic lymphocytic leukemia (CLL).

Integrated habitat imaging models predicted early hepatocellular carcinoma (HCC) recurrence by identifying MVI and VETC risk.

A utility-based SBRT dose selection strategy improved predicted overall outcomes for patients with hepatocellular carcinoma (HCC).

The role of gut microbiota continues to be elucidated in the progression, diagnosis, and treatment of hepatocellular carcinoma (HCC).

A pregnancy affected by FNAIT can cause lasting harm to the mother’s psychological well-being even after the baby has left the hospital.

The US Food and Drug Administration (FDA) has recently expanded the approval of Gamifant ® (emapalumab-lzsg) to include the treatment of adult and pediatric (newborn or older) patients with ...

Which of the statements below about the treatment of hepatocellular carcinoma (HCC) are correct? Select one of the options for each question, then submit your answers to see how well you scored. Read ...

Careful attention to blood sample handling, including maintaining a warm chain, can help identify cold agglutinin disease (CAD).

Routine immunoglobulin G (IgG) monitoring may help identify pediatric patients with acute lymphoblastic leukemia (ALL) at risk for hypogammaglobulinemia and frequent febrile episodes during ...

Serum transthyretin levels appear to correlate with worse prognosis in patients with transthyretin amyloid cardiomyopathy (ATTR-CM), a study found.

The suspicion of cardiac amyloidosis is still age-biased among healthcare professionals. In spite of recent educational efforts.

Emicizumab is one of the most important innovations in hemophilia A therapeutics that has been made available in recent years.